Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/174786
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ramos Campo, Domingo J. | - |
dc.contributor.author | Ávila Gandía, Vicente | - |
dc.contributor.author | López Román, Fco. Javier | - |
dc.contributor.author | Miñarro, José | - |
dc.contributor.author | Contreras, Carlos | - |
dc.contributor.author | Soto Méndez, Fulgencio | - |
dc.contributor.author | Domingo i Pedrol, Joan Carles | - |
dc.contributor.author | Luque Rubia, Antonio J. | - |
dc.date.accessioned | 2021-03-08T17:38:13Z | - |
dc.date.available | 2021-03-08T17:38:13Z | - |
dc.date.issued | 2020-03-09 | - |
dc.identifier.issn | 2072-6643 | - |
dc.identifier.uri | http://hdl.handle.net/2445/174786 | - |
dc.description.abstract | This study aimed to analyse the e ect of 10 weeks of a highly concentrated docosahexaenoic acid (DHA) + eicosapentaenoic (EPA) supplementation (ratio 8:1) on strength deficit and inflammatory and muscle damage markers in athletes. Fifteen endurance athletes participated in the study. In a randomized, double-blinded cross-over controlled design, the athletes were supplemented with a re-esterified triglyceride containing 2.1 g/day of DHA + 240 mg/day of EPA or placebo for 10 weeks. After a 4-week wash out period, participants were supplemented with the opposite treatment. Before and after each supplementation period, participants performed one eccentric-induced muscle damage exercise training session (ECC). Before, post-exercise min and 24 and 48 h after exercise, muscle soreness, knee isokinetic strength and muscle damage and inflammatory markers were tested. No significant differences in strength deficit variables were found between the two conditions in any of the testing sessions. However, a significant effect was observed in IL1 (p = 0.011) and IL6 (p = 0.009), which showed significantly lower values after DHA consumption than after placebo ingestion. Moreover, a significant main effect was observed in CPK (p = 0.014) and LDH-5 (p = 0.05), in which significantly lower values were found after DHA + EPA consumption. In addition, there was a significant effect on muscle soreness (p = 0.049), lower values being obtained after DHA + EPA consumption. Ten weeks of re-esterified DHA + EPA promoted lower concentrations of inflammation and muscle damage markers and decreased muscle soreness but did not improve the strength deficit after an ECC in endurance athletes. | - |
dc.format.extent | 17 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | MDPI | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3390/nu12030719 | - |
dc.relation.ispartof | Nutrients, 2020, vol. 12, num. 719 | - |
dc.relation.uri | https://doi.org/10.3390/nu12030719 | - |
dc.rights | cc-by (c) Ramos Campo et al., 2020 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es | - |
dc.source | Articles publicats en revistes (Bioquímica i Biomedicina Molecular) | - |
dc.subject.classification | Exercici | - |
dc.subject.classification | Creatina quinasa | - |
dc.subject.classification | Àcids grassos omega-3 | - |
dc.subject.other | Exercise | - |
dc.subject.other | Creatine kinase | - |
dc.subject.other | Omega-3 fatty acids | - |
dc.title | Supplementation of re-esterified docosahexaenoic and eicosapentaenoic acids reduce inflammatory and muscle damage markers after exercise in endurance athletes: a randomized, controlled crossover trial | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 699512 | - |
dc.date.updated | 2021-03-08T17:38:13Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 32182747 | - |
Appears in Collections: | Articles publicats en revistes (Bioquímica i Biomedicina Molecular) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
699512.pdf | 2.91 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License